Bharat Biotech’s COVAXIN, India’s first indigenous vaccine against coronavirus.The government on Friday (7 January) slammed media reports suggesting that the approval for Covaxin vaccine for 15-18 years age group has been given despite the World Health Organisation (WHO) not having accorded Emergency Use Listing (EUL) to its use in this age bracket.
"Such reports are highly ill- informed, misleading and far from the truth," the Union Health Ministry said in a statement.
The ministry said that the guidelines issued by the government at no place mention about EUL by WHO.
The guidelines issued by the Union Health Ministry on December 2021, under the heading “New beneficiaries aged 15-18 years” state that "For such beneficiaries, option for vaccination would only be available for Covaxin as this is the only vaccine with EUL for the age-group 15-18", the ministry said.
The EUL by Central Drugs Standard Control Organisation (CDSCO), the national regulator, for Covaxin vaccine for the 12-18 age group was accorded on 24 December 2021.
Subsequently, the Guidelines for vaccination of 15-18 yr age group of young adults and precaution dose for other identified categories was issued by a Union Health Ministry on 27 December 2021, the ministry added.
- Health ministry ,
- WHO ,
- CDSCO ,
- EUL ,
An Appeal...
Dear Reader,
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.